Richard Pollak
Foot & Ankle Surgery · San Antonio, TXNPI 1912923731
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (51.4%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Heron Therapeutics, Inc. accounts for 66.6% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2021 at $13,415 and has fallen 99.8% since, to $25 in 2025.
Across 125 payments — averaging $255.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Heron Therapeutics, Inc.$21K
- Vertex$2K
- Endo Pharmaceuticals Inc.$2K
- Stryker$2K
- Kowa Pharmaceuticals America, Inc.$1K
- Merck$922
- plus $2K from 16 others
Across 91 payments — averaging $67,032 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Heron Therapeutics, Inc.$2.4M
- Vertex$2.2M
- Acadia Pharmaceuticals Inc$1M
- Endo Pharmaceuticals Inc.$366K
- Globus Medical$55K
- Sanofi Pasteur Inc.$36K
- plus $68K from 3 others
What the payments were for
- Consulting fees$16,42051%
- Speaking & faculty fees$7,83825%
- Travel & lodging$3,84612%
- Food & beverage$3,86912%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Heron Therapeutics, Inc. | 18 | $21,309 |
| Vertex | 4 | $2,395 |
| Endo Pharmaceuticals Inc. | 7 | $2,325 |
| Stryker(2 entities) | 38 | $2,014 |
| Kowa Pharmaceuticals America, Inc. | 1 | $1,395 |
| Merck | 7 | $922 |
| Organogenesis Inc. | 8 | $380 |
| Paratek Pharmaceuticals, Inc. | 11 | $279 |
| Trilliant Surgical LLC. | 3 | $252 |
| Sebela Pharmaceuticals Inc. | 3 | $135 |
| Smith+Nephew | 7 | $116 |
| Pacira Pharmaceuticals Incorporated | 2 | $108 |
| Integra Lifesciences Corporation | 3 | $61 |
| Kerecis Limited | 1 | $53 |
| Amgen | 3 | $53 |
| Medartis Inc. | 1 | $52 |
| Acera Surgical, Inc. | 2 | $34 |
| Melinta Therapeutics, LLC | 2 | $29 |
| Sandoz | 1 | $18 |
| Avanos Medical | 1 | $16 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $15 |
| Arthrosurface Incorporated | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$31,973 in reported general payments places this provider in the 85th percentile of 684 foot & ankle surgery providers in Texas.
Other foot & ankle surgery in San Antonio
- Ian BarronSan Antonio$162K
- Walter StrashSan Antonio$86K
- Thomas ZgonisSan Antonio$79K
- Collin PehdeSan Antonio$49K
- William McGarveyKaty$3.5M
- Eugene CurryDallas$3.1M
- Graham HamiltonEdinburg$2.1M
- Mark DaltonAustin$1.9M
- Kevin VarnerHouston$1.1M
- Paul KimDallas$928K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.